{
  "docId": "019de070-301c-70bd-a010-9a413c6f1b9e",
  "docSlug": "98da217852cb2fba9da82ffbc6cfdefe",
  "documentTitle": "Genetron | IPO Presentation Deck | 41 slides",
  "authorId": "genetron",
  "authorName": "Genetron",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 21,
  "pageCount": 41,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": "The slide uses a flow diagram to illustrate the clinical study methodology and results.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-301c-70bd-a010-9a413c6f1b9e/21",
  "deckHref": "/decks/019de070-301c-70bd-a010-9a413c6f1b9e",
  "deckJsonHref": "/decks/019de070-301c-70bd-a010-9a413c6f1b9e.json",
  "deckAnchorHref": "/decks/019de070-301c-70bd-a010-9a413c6f1b9e#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.88,
        "x": 0.06,
        "y": 0.0038
      },
      "kind": "diagram",
      "text": "Flowchart showing 3,793 HBV positive patients split into AFP/US positive/negative, then into training/validation cohorts, and finally HCCscreen positive/negative outcomes.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39e16ce3-0cf7-4e1c-bb8f-77a395104eda",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.06,
        "y": 0.0022
      },
      "kind": "list",
      "text": "Study based on collaboration with National Cancer Center of China: government funded semi-annual follow-up and blood sample collection\nChina's only prospective and peer-reviewed study published on liver cancer early screening",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6269dd7a-3558-493c-b7b3-140c413639d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.88,
        "x": 0.06,
        "y": 0.0018
      },
      "kind": "paragraph",
      "text": "Genetron's groundbreaking study published in Mar 2019",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82540b45-5aec-491a-ac02-22e503c9bc26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.04,
        "y": 0.0094
      },
      "kind": "source-note",
      "text": "(1) Training cohort on patients who had liver nodules and/or elevated serum AFP levels",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36d535b5-88de-4198-b350-01390f6a47d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.88,
        "x": 0.06,
        "y": 0.0074
      },
      "kind": "table",
      "text": "Training cohort: 85% sensitivity, 93% specificity. Validation cohort: 100% sensitivity, 94% specificity, 17%+ PPV.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6bd651d-54fb-40c5-9060-53d49b37f899",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.92,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "HCCscreen™: a potential blockbuster early liver cancer screening test with exciting clinical data",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b91e2c28-e13b-442b-abf3-6759eb217af6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "f5965495-76ed-4734-91a2-7ed34bcaf317",
      "evidence": "Flowchart of clinical study methodology",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 23,
      "from": 20,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "61b77ce9-0007-412c-946f-5eeb0ac73f80",
      "evidence": "Slides 20-23 discuss the significant cost advantage presented by Genetron's proprietary technologies and recent development",
      "position": 0,
      "objective": "Highlight the benefits of Genetron's proprietary technologies and significant progress on public medical insurance",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 24,
      "from": 21,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "88fc9991-bd55-435a-bdbb-a386748f4ad0",
      "evidence": "Slides 21-24 discuss HCCscreen™ and its exciting clinical data",
      "position": 1,
      "objective": "Highlight the potential of HCCscreen™ as a blockbuster early liver cancer screening test",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}